Passage BIO, Inc. - PASG

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$6.811M
QoQ value delta ($000)
-$7.003M (-50.69%)
Implied price effect (QoQ)
-37.23%
Shares
Total shares
1,398,180
QoQ shares delta
-381,868 (-21.45%)
Total shares held by funds (by quarter)

Market chart (PASG)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 29 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Lynx1 Capital Management LP 3,287 673,759 0.38%
VANGUARD CAPITAL MANAGEMENT LLC 556 113,964 0.0%
BALYASNY ASSET MANAGEMENT L.P. 522 107,025 0.0%
Ikarian Capital, LLC 485 99,517 0.05%
Yiheng Capital Management, L.P. 420 86,097 0.14%
RENAISSANCE TECHNOLOGIES LLC 233 47,892 0.0%
Erste Asset Management GmbH 197 40,665 0.0%
GEODE CAPITAL MANAGEMENT, LLC 180 37,026 0.0%
Verdad Advisers, LP 149 30,728 0.14%
BOOTHBAY FUND MANAGEMENT, LLC 138 28,439 0.0%
BlackRock, Inc. 136 27,910 0.0%
ACADIAN ASSET MANAGEMENT LLC 109 22,496 0.0%
VANGUARD FIDUCIARY TRUST CO 83 17,049 0.0%
DELTEC ASSET MANAGEMENT LLC 73 15,000 0.01%
UBS Group AG 66 13,565 0.0%
HRT FINANCIAL LP 62 12,712 0.0%
FIDUCIARY TRUST CO 52 10,750 0.0%
GTS SECURITIES LLC 48 10,000 0.0%
MORGAN STANLEY 11 2,389 0.0%
Vanguard Global Advisers, LLC 3 638 0.0%
BARCLAYS PLC 1 212 0.0%
JPMORGAN CHASE & CO 0 15 0.0%
WELLS FARGO & COMPANY/MN 0 115 0.0%
HARBOUR INVESTMENTS, INC. 0 3 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 12 0.0%